C

Cyclerion Therapeutics
D

CYCN

1.73000
USD
-0.04
(-2.26%)
Market Closed
Volume
6
EPS
0
Div Yield
0
P/E
-0
Market Cap
4,352,462
OverviewSignalsIdeasNews
Related Instruments
    A
    APTO
    -0.03680
    (-6.57%)
    0.52320 USD
    A
    ARLO
    -0.590
    (-3.89%)
    14.590 USD
    C
    CRVS
    0.36000
    (13.85%)
    2.96000 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    E
    EOLS
    1.660
    (13.38%)
    14.070 USD
    F
    FUTU
    -3.650
    (-5.77%)
    59.630 USD
    K
    KPTI
    -0.06290
    (-6.37%)
    0.92380 USD
    N
    NKTX
    -0.03000
    (-0.47%)
    6.41000 USD
    P
    PRVB
    -0.075
    (-0.31%)
    23.870 USD
    More
News

Title: Cyclerion Therapeutics

Sector: Healthcare
Industry: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.